Prosperity of celecoxib for pain relief after elective cesarean section delivery, a double-blind randomized controlled trial

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

TCTR

Registry ID

TCTR20190109003

Enrollment

100

Registered

2019-01-09

Start date

2018-05-09

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

celecoxib 400 mg oral at post&#45

op 2 hours,Placebo oral at Post&#45

op 2 hours

Experimental Drug,No Intervention No treatment

treatment group,Placebo group

Eligibility

Sex/Gender

Female

Age

20 Years to 40 Years

Inclusion criteria

Inclusion criteria: -term prgnancy -singleton -age 20 â€“ 40 year-old -elective cesarean section or cesarean section with tubal sterilization -Pfannenstiel incision -spinal block -BMI < 35 kg/mm2

Exclusion criteria

Exclusion criteria: No history of NSAIDs,sulfa group and opioid groug allery No liver,hematology,renal and heart disease No currently warfarin tak Opertive time <= 2 hours Blood loss<= 1000 ml

Design outcomes

Primary

Measure	Time frame
Pain score at rest and movement 24 hour Visual analogue scale,Pain score at rest and movement 6 and 12 hours Visual analogue scale	—

Secondary

Measure	Time frame
PCA pethidine used 24 hours milligram,Pain score at rest and movement 6 and 12 hours visual analogue scale	—

Countries

Thailand

Contacts

Public Contactthunwipa tuscharoenporn

Faculty of Medicine Vajira Hospital, Navamindradhiraj University

thunwipatus@gmail.com0819290001

Outcome results